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Paramyxoviral infection in childhood has been linked to a significant increased rate of 
asthma development. In mice, paramyxoviral infection with the mouse parainfluenza virus 
type I, Sendai virus (Sev), causes a limited bronchiolitis followed by persistent asthma 
traits. We have previously shown that the absence of cysteine protease dipeptidyl pep-
tidase I (DPPI) dampened the acute lung inflammatory response and the subsequent 
asthma phenotype induced by Sev. Adoptive transfer of wild-type neutrophils into DPPI-
deficient mice restored leukocyte influx, the acute cytokine response, and the subsequent 
mucous cell metaplasia that accompanied Sev-induced asthma phenotype. However, 
the exact mechanism by which DPPI-sufficient neutrophils promote asthma development 
following Sev infection is still unknown. We hypothesize that neutrophils recruited to the 
alveolar space following Sev infection elaborate neutrophil extracellular traps (NETs) that 
propagate the inflammatory cascade, culminating in the eventual asthma phenotype. 
Indeed, we found that Sev infection was associated with NET formation in the lung 
and release of cell-free DNA complexed to myeloperoxidase in the alveolar space and 
plasma that peaked on day 2 post infection. Absence of DPPI significantly attenuated 
Sev-induced NET formation in vivo and in vitro. Furthermore, concomitant administration 
of DNase 1, which dismantled NETs, or inhibition of peptidylarginine deiminase 4 (PAD4), 
an essential mediator of NET formation, suppressed the early inflammatory responses to 
Sev infection. Lastly, NETs primed bone marrow-derived cells to release cytokines that 
can amplify the inflammatory cascade.
Keywords: neutrophils, neTs, cytokines, dipeptidyl peptidase i, sendai virus-induced asthma
inTrODUcTiOn
Respiratory viral illnesses are common in early life. A majority of children with an initial episode 
of viral-induced bronchiolitis will have recurrent wheezing, prompting the association between 
viral infection, and subsequent development of asthma (1–3). In the mouse, infection with the 
paramyxovirus Sendai virus (Sev) causes a limited bronchiolitis followed by chronic persistent 
asthma traits characterized by mucous cell metaplasia and airway hyperreactivity (AHR) (4). 
We have previously shown that the asthma phenotype was attenuated in the absence of dipep-
tidyl peptidase I (DPPI), a cysteine protease with many immunomodulatory activities (5). This 
attenuation was accompanied by significant reduction in the number of alveolar neutrophils 
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and local production of inflammatory cytokines in the acute 
phase of infection. Adoptive transfer of WT neutrophils into 
DPPI-deficient mice led to enhanced accumulation of DPPI-
deficient neutrophils and inflammatory cytokine production in 
the alveolar space on day 4 post-infection (PI) and subsequent 
asthma phenotype development. The fact that DPPI-deficient 
neutrophils exhibited normal chemotaxis in response to various 
stimuli (5) but failed to accumulate at the site of inflamma-
tion (alveolar space) suggests a yet-to-be defined mechanism 
by which DPPI and DPPI-sufficient neutrophils modulate the 
early inflammatory responses to Sev.
Neutrophil extracellular traps (NETs) were initially described 
as a neutrophil defense mechanism to trap and kill bacteria 
(6). NETs have since been implicated in the pathogenesis of 
several inflammatory diseases, including bronchial asthma (7). 
Herein, we showed that Sev infection led to NET formation in 
the lung of WT mice. We also established that DPPI-deficient 
neutrophils exhibited a defect in NET formation in  vitro in 
response to multiple stimuli. We hypothesized that the absence 
of DPPI attenuated NET formation in response to Sev infection, 
thus interrupting the inflammatory cascade and suppressing the 
ongoing leukocyte influx. Indeed, administration of DNase 1, 
which dismantled NETs, reduced free DNA–myeloperoxidase 
(MPO) complexes in the alveolar space and plasma, as well as 
attenuating the early inflammatory responses to Sev infection. 
Inhibition of peptidylarginine deiminase 4 (PAD4), an essential 
mediator of NET formation also suppressed alveolar leukocyte 
accumulation and cytokine production in the acute phase of 
infection, confirming the contribution of NETs to Sev-induced 
phenotype. Moreover, NETs from Sev-infected bronchoalveolar 
lavage fluid (BALF) stimulated bone marrow-derived cells 
(BMDCs) [dendritic cells (DCs) and macrophages] to release 
inflammatory cytokines.
MaTerials anD MeThODs
animals
Dipeptidyl peptidase I−/− mice were generated in 129/SvJ as previ-
ously described (8) and backcrossed to C57BL/6J for >10 genera-
tions. Microsatellite genotyping showed that DPPI−/− mice were 
99.2% congenic with C57BL/6J mice (The Jackson Laboratory). 
WT C57BL/6J mice were obtained from The Jackson Laboratory. 
WT and DPPI−/− mice were kept in pathogen-free environment 
until the time of Sev infection. All animal experiments were per-
formed in compliance with federal laws and in strict accordance 
with the guidelines established by the Division of Comparative 
Medicine at Washington University in St. Louis.
Viral infection
Mice of 6–8 weeks of age were anesthetized with isoflurane and 
inoculated intranasally (i.n.) with 2,500 50% egg infectious dose 
of Sev (Fushimi strain) as previously described (5). Experimental 
infection with Sev was performed in biohazard containment facil-
ity. Some animals received DNase 1 (0.5 mg i.n./mouse) on days 
0–2. Cl-amidine, a pan-PAD inhibitor (cat#506282, Calbiochem) 
was dissolved in DMSO/PBS (5% v/v) and administered i.p. at 
10 mg/kg daily on days −2 and −1 prior to infection then twice a 
day on days 0–2 PI. Controls received the same volume of DMSO/
PBS (5% v/v). At different time points, mice were sacrificed and 
their blood, BALF, and lung harvested for cell count, cytokine, 
MPO–DNA, and histologic analysis.
lung and BalF analysis
After sacrifice, BALF was obtained as previously described (5). The 
cells were pelleted and analyzed by flow cytometry using: FITC 
anti-CD69 (cat# 561929; BD Pharmingen), PerCP anti-CD8a 
(cat# 45-0081-82; eBioscience), APC anti-CD4 (cat# 100516; 
BioLegend), PE anti-CD11c (cat#553802, BD Pharmingen), anti-
Siglec-H (cat# MCA4647GA, AbD Serotec, Raleigh, NC, USA), 
APC anti-CD317 (cat# 127015, BioLegend), PerCP anti-CD11b 
(cat# 101229, BioLegend), FITC anti-rat IgG (cat# 712-095-150, 
Jackson ImmunoResearch Laboratories). In general, 106 cells were 
blocked with the anti-FcR mAb 2.4G2, stained with the indicated 
antibodies for 20 min at 4°C and then washed and resuspended 
in FACS buffer for analysis. Flow cytometry was performed on 
a BD FACSCalibur™. Data analysis was performed using BD 
CellQuest™ Pro software. Cell-free BALF was subjected to 
cytokine analysis by cytometric bead arrays (CBA) or MPO–DNA 
complex analysis. The lung was snap frozen in OCT compound 
and examined for in vivo NET formation.
In Vivo neT Detection
Cross sections (9  μm) of OCT-embedded frozen lung tissues 
were fixed in 4% paraformaldehyde, blocked in 8% BSA in PBS 
and incubated with the primary antibodies: anti-Histone H2B 
(1:100 dilution; Cat # SC-8651; Santa Cruz Biotechnology), anti-
mouse MPO (1:100 dilution; Cat # HM1051BT; Hycult Biotech) 
followed by the appropriate rhodamine red- or FITC-conjugated 
secondary antibody (1:100–1:200; Jackson ImmunoResearch 
Laboratories). DNA was stained with DAPI. All images were 
acquired with QCapture software on a Nikon Eclipse microscope.
In Vitro neT induction
Neutrophils were isolated from bone marrow as previously 
described (9). Isolated neutrophils were seeded on Thermanox 
plastic coverslips (Cat # 174950, Thermo Fisher Scientific Inc.) or 
5-mm round glass coverslips (Cat # 101413-528, VWR), placed 
in 24-well plates (75,000 cells/well) and incubated for 1  h at 
37°C to allow adherence to coverslips. The following activating 
agents were used: LPS (10 μg/ml, Cat # L2762, Sigma-Aldrich), 
PMA (10 nM, cat# P8137, Sigma-Aldrich) or Sev (5,000), and 
rmTNF-α (10 μg/ml, cat# 410-MT, R&D Systems). After 30 min 
of stimulation, cells were fixed with 4% paraformaldehyde in 
PBS overnight and the DNA was stained with Sytox green (Cat # 
S7020, Invitrogen). NETs were visualized on a Nikon Eclipse 
fluorescence microscope and low magnification images (40×) 
were acquired with QCapture software on non-overlapping 
random images (7–11 separate fields/coverslips, derived from 
3 wells/condition or genotype). NETs were manually identified 
on acquired images as Sytox-positive structures emanating 
from neutrophils with an overall length at least twice as long 
as the cell diameter (10) and expressed as percentage of neu-
trophils with released DNA. Each experiment was repeated at 
least three times.
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MPO–Dna elisa
Anti-MPO antibody (5 μg/ml, cat# HM 1051BT, Hycult Biotech 
Inc) was used to coat 96-well plate overnight at 4°C. After three 
washes with washing buffer (PBS with 0.05% Tween 20), 20 μl 
of BALF or plasma samples were added to the wells with 80-μl 
incubation buffer containing a peroxidase-labeled anti-DNA 
monoclonal antibody (dilution 1:25, cat# 11544675001, Cell 
Death Detection ELISA, Roche). The plate was incubated for 2 h 
at room temperature. After three washes, 100 μl of peroxidase 
substrate (cat# DY999, R&D Systems) was added. The reaction 
was stopped with 1M H2SO4 and OD of samples measured at 
450 nm (Molecular Devices SpectraMax Plus 384). Specific OD 
was obtained by subtracting total OD from background OD 
generated without the addition of peroxidase-labeled anti-DNA 
antibody (less than 10%).
cytokine analysis
Cytokine concentrations in BALF samples and co-cultures 
were measured using the CBA for Mouse Inflammation Kit 
(cat# 552364, BD Biosciences), according to the manufacturer’s 
protocols.
In Vitro co-cultures
Murine bone marrow cells were cultured in vitro with GM-CSF 
(10  μg/ml, cat# PMC2015, Thermo Fisher Scientific) and Il-4 
(5 μg/ml, cat# 404-ML/CF, R&D Systems) for 7 days. Cultured 
cells were plated in 24-well plates at 0.5 × 106 cells/well. BALF col-
lected on day 3 from Sev-infected mice were added at a final dilu-
tion of 44%. Supernatants were collected 2 days later and cytokine 
concentrations were analyzed by CBA. Baseline cytokine levels 
from BMDCs alone are subtracted from co-culture cytokine 
levels and values are presented as% of mean WT level, which is 
set at 100%.
statistical analysis
Comparisons between two groups were performed by student’s 
t-test and comparisons between multiple groups (≥3) were per-
formed by one-way ANOVA and Bonferroni’s correction for mul-
tiple comparisons was performed. Numerical data were expressed 
as mean ± SEM. P values <0.05 were considered significant.
resUlTs
sev infection induces neT Formation 
In Vivo and In Vitro
WT C57BL/6J and DPPI-deficient (DPPI−/−) mice were infected 
i.n. with 2,500 50% egg infectious dose of Sev as previously 
described (5). On day 3 PI, mice were sacrificed and their lung 
examined for NET formation by immunostaining with anti- 
histone and anti-MPO antibodies; DAPI stained DNA. NETs were 
easily detected in WT lung but greatly decreased in DPPI−/− mice 
(Figure  1A). Concomitant administration of DNase 1, which 
dismantled NETs (11, 12), also suppressed Sev-induced NET 
formation in Sev-infected WT mice (Figure 1A).
To further quantify the NET content in Sev-infected mice we 
measured concentration of MPO–DNA complexes in the BALF 
and in plasma. The concentration of MPO–DNA complexes 
in BALF and plasma was increased in Sev-infected WT mice 
(Figures 1B,C). By contrast, we detected significantly lower levels 
of MPO–DNA complexes in the lung and plasma of Sev-infected 
DPPI−/− mice on days 2–4 PI (Figures 1B,C). DNase 1 treatment 
also lowered the concentration of MPO–DNA complexes in 
BALF and plasma, confirming that the release of these complexes 
was partly NET dependent (Figure 1D).
In vitro, Sev enhanced NET release from TNF-primed, bone 
marrow-derived WT neutrophils (Figure  2). TNF-primed 
DPPI−/− neutrophils generated lower levels of NETs in response 
to Sev (Figure 2) although the overall rate of Sev-induced NET 
formation was lower compared to PMA or LPS stimulation 
(Figure 2). Regardless of the stimulus, DPPI−/− neutrophils con-
sistently generated lower level of NETs, consistent with the in vivo 
results and previous studies (13, 14). Taken together these results 
suggest that Sev can directly induce NETs; however, in the lung 
milieu following Sev infection, several inflammatory cytokines 
likely contribute to or enhance Sev-induced NET formation.
Dnase 1 attenuates the early  
sev-induced alveolar inflammation
We have previously shown that Sev infection induced the expres-
sion of several cytokines/chemokines and absence of DPPI 
dampened this acute inflammatory response (5). To determine 
whether NETs modulated the acute response following Sev infec-
tion, we examined alveolar leukocyte accumulation and cytokine 
expression in WT mice treated with DNase 1. Administration of 
DNase 1 (i.n.) significantly reduced the total number of leuko-
cytes recruited to the alveolar space (Figure 3). In addition, the 
levels of several BALF inflammatory cytokines, including TNF-α 
and IL-6 were suppressed with DNase 1 treatment (Figure 3). The 
extent of suppression with DNase1 treatment was equivalent to 
that observed with DPPI−/− mice (Figure 3). DNase 1 treatment 
not only suppressed the acute cytokine response but also damp-
ened the recruitment and activation of CD4+ and CD8+ T cells, as 
well as plasmacytoid DCs (CD317+ CD11c+ CD11b− Siglec-H+) 
(Figure 4).
To further confirm that NET plays a role in the early inflam-
matory responses to Sev infection, we administered Cl-amidine, 
a pan PAD inhibitor with preferential irreversible inactivation of 
the calcium bound form of PAD4 (15, 16) to Sev-infected mice. 
PAD4 catalyzes the conversion of specific arginine residues to cit-
rulline (17) and is essential for the formation of NETs via PAD4-
mediated citrullination of histones (18). Cl-amidine suppressed 
neutrophil accumulation and inflammatory cytokine release in 
the alveolar space (Figure 5). Combined with the DNase 1 treat-
ment results, these findings further confirmed the involvement of 
NETs in early host responses to Sev.
neT containing BalF stimulates 
Dendritic cells/Macrophages to 
release inflammatory cytokines
Previous studies suggest that the early phase antiviral cytokine 
response correlates with chronic lung immunopathology, includ-
ing the airway remodeling and AHR that accompany the asthma 
FigUre 1 | sev infection induces pulmonary neTs. WT and DPPI−/− mice were infected with Sev and their blood, lung, and BALF harvested on the indicated 
day PI. (a) Frozen lung sections from day 3 PI were stained for histone (green) and MPO (red). DAPI stained nuclei blue. The absence of DPPI and DNase 1 
treatment suppressed NET formation. (B–D) BALF fluid and plasma from Sev-infected animals were collected on the indicated days and assayed for levels of 
MPO–DNA complexes. Values represent increase over baseline (obtained from uninfected mice) and expressed as mean ± SEM, n = at least five mice per 
genotype/treatment group. Scale bars = 100 μm. *P < 0.05, ***P < 0.001.
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phenotype (19). In addition to Th2-types cytokines, Th1 cytokines, 
such as TNF-α, have also been shown to play an important role 
in the pathogenesis of asthma. TNF-α is increased in the sputum 
of patients with asthma (20, 21), aggrevates AHR (22) as well as 
recruit inflammatory cells in animals (23). Blockade of TNF-α 
significantly inhibits AHR and reduces airway inflammation (24). 
To this end, we examined whether BALF-derived NETs from 
Sev-infected mice modulated TNF-α (and other inflammatory 
cytokine) release from in  vitro GM-CSF-induced BMDCs that 
comprise conventional DCs and macrophages (25). We observed 
that NET-containing BALF from WT Sev-infected mice directly 
stimulated BMDCs to release substantial amount of TNF-α (as well 
as IL-6 and MCP-1) while BALF from DPPI−/− mice and animals 
treated with DNase 1 was less efficient (Figure 6A). Cl-amidine 
FigUre 2 | absence of DPPi attenuates neT formation in vitro. (a) Bone marrow-derived neutrophils from WT and DPPI−/− mice were stimulated with 
TNF-α + Sev, PMA, or LPS for 30 min and stained for DNA with Sytox green. (B,c) Quantification of NETs with different stimuli (mean ± SEM derived from three 
separate experiments). *P < 0.05, **P < 0.01, ***P < 0.001.
FigUre 3 | Dnase 1 treatment suppresses the acute sev-induced inflammatory responses. WT and DPPI−/− mice were infected with Sev and their BALF 
harvested on day 3 PI. Some WT mice received DNase 1 i.n. on days 0–2 PI. The cells were enumerated and cell-free BALF assayed for cytokines by CBA. Values 
represent mean ± SEM, n = 4–5 mice per genotype/treatment group. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant.
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FigUre 5 | cl-amidine administration attenuates acute sev-induced inflammatory responses. WT mice were administered Cl-amidine i.p. daily 2 days 
prior to infection and treatment was continued (twice a day) until sacrifice as detailed in Section “Materials and Methods.” Controls received the same i.p. regimen of 
DMSO/PBS (5% v/v). On day 3 BALF was collected; cells were enumerated and cell-free BALF assayed for cytokines by CBA. Values represent mean ± SEM, n = 5 
mice/treatment group. **P < 0.01; ***P = 0.001; note that IL-6 level in Cl-amidine treatment group approached statistical significance (P = 0.06).
FigUre 4 | Dnase 1 treatment suppresses immune cell recruitment and activation. WT mice were infected with Sev and treated i.n. with HBSS or DNase 1. 
Cells were harvested from BAL on day 3 PI and analyzed for CD4, CD8, CD69 (activation marker), and CD317+CD11c+CD11b-SiglecH+ (plasmacytoid dendritic 
cell markers) by multicolor FACS analysis. Values represent mean ± SEM, n = 4–5 mice/treatment group. *P < 0.05, **P < 0.01.
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treatment also significantly attenuated the release of inflamma-
tory cytokines by BALF-stimulated BMDCs (Figure 6B). Taken 
together, these above findings suggest that NETs released by 
recruited neutrophils play an important role in shaping the early 
immune response that likely impacts the Sev-induced chronic 
lung immunopathology.
DiscUssiOn
Neutrophil extracellular traps can have anti- and pro-inflammatory 
effects on disease pathogenesis. On the one hand, NETs have been 
shown to promote the resolution of neutrophilic inflammation 
in monosodium urate crystal-induced arthritis (gout) (26). On 
the other hand, NETs are increasingly implicated in driving the 
pathogenesis of various diseases (11, 27–31). Their role in asthma 
development, however, remains largely unknown. Asthma is con-
sidered an inflammatory disease involving different mediators 
and cell types, with eosinophil predominance. Non-eosinophilic 
asthma, however, comprises 50% of asthma and is often associ-
ated with accumulation of neutrophils in the airways, possibly 
due to bacterial endotoxin exposure as well as viral infections 
(32). Neutrophils are often present in acute asthma exacerbations 
(33) and noted in specific circumstances, such as status asth-
maticus (34) but their role in asthma pathogenesis has not been 
extensively explored. A more recent study suggests that NETs are 
generated in human atopic asthmatic airways (35); however, their 
pathophysiologic role in allergic asthma also remains undefined. 
Using a physiologic murine model of Sev-induced asthma phe-
notype, we previously established a critical role for neutrophils 
and neutrophil-associated DPPI in the disease pathogenesis (5). 
In the studies herein, we further extend the investigation to show 
that neutrophil-derived DPPI is an important mediator of NET 
formation and NETs mediate the early inflammatory responses 
in Sev infection.
In addition to Sev-induced asthma phenotype, the absence 
of DPPI protects against various inflammatory conditions, 
FigUre 6 | BalF from sev-infected mice stimulates cytokine release from BMDcs. WT and DPPI−/− mice were infected with Sev on day 0. Some WT mice 
were treated i.n. with DNase 1 or Cl-amidine as detailed in Section “Materials and Methods.” BALF was harvested on day 3 PI and cells were pelleted. The cell-free 
BALF from each genotype/treatment was added to BMDCs at a final dilution of 44%. The supernatant was collected after 48 h and assayed for cytokine levels with 
CBA. (a) Cytokine levels from co-cultures of BMDCs with BALF from WT, DPPI−/−, or DNase 1-treated (Tx) mice. (B) Cytokine levels from co-cultures of BMDCs with 
BALF from Cl-amidine-treated mice. Values represent mean ± SEM, n = 4–6 mice/treatment group. The mean of WT cytokine levels for each experimental condition 
was set at 100%; values are expressed as% of mean WT level. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant.
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including preclinical models of rheumatoid arthritis (36), sepsis 
(37), abdominal aortic aneurysm (38), and ANCA-associated 
glomerulonephritis (39). DPPI deficiency also attenuates early 
atherosclerotic lesion in LDL-receptor-deficient mice (40). 
A recent report established that the absence of DPPI abrogates 
in  vitro NET formation (13). DPPI is a ubiquitously expressed 
cysteine protease that is required for the expression of neutrophil 
serine proteases (NSPs), neutrophil elastase (NE), cathepsin G 
(CG) and proteinase 3 (PR3) in mature neutrophils (13, 36, 41). 
The role of NSPs in NET formation is well accepted (42). It is 
suggested that NE, but not CG or PR3, translocates to the nucleus 
where it contributes to chromatin decondensation by cleaving 
histones, an essential step in NET formation (43, 44). However, 
Martinod et al. recently showed that NE is dispensable for in vitro 
and in vivo NETs (45). Consistent with these results, we found 
that murine NE-deficient neutrophils release normal levels of 
NETs in vitro in response to various stimuli while the absence of 
NE and PR3 results in a NET defect similar to that observed with 
DPPI-deficient neutrophils (14). These discrepancies may reflect 
species-dependent requirements for NET formation, as previous 
studies used human neutrophils and NSP inhibitors.
Airway remodeling is an important histologic and struc-
tural change seen in asthma. It is a complex and incompletely 
understood process, involving several cell types and mediators. 
Neutrophils have been linked to airway remodeling presumably 
through their ability to release proteases, including metallopro-
teases and NE that induce degradation of extracellular matrix and 
modulate inflammatory cell trafficking (46–48). Herein, we show 
that DNase 1 treatment significantly reduced the recruitment and 
activation of leukocytes, including CD4+ and CD8+ T cells, in 
the acute phase PI and suppressed inflammatory cytokine release. 
BALF from DNase 1- and Cl-amidine-treated animals was also 
less efficient at stimulating bone marrow-derived macrophages 
and DCs from releasing inflammatory cytokines. Taken together 
these results suggest that NETs released during the acute phase 
of Sev infection induce airway inflammation, leading to the 
elaboration of inflammatory cytokines that further recruit and 
activate immune cells, thus promoting the eventual chronic 
asthma phenotype.
In summary, these findings suggest that controlling neutrophil 
activation and NET formation in non-eosinophilic asthma may 
attenuate acute exacerbations and potentially prevent further 
airway remodeling.
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